Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of<i>Klebsiella pneumoniae</i>and<i>Mycobacterium tuberculosis</i>as a drug target enzyme: insights from molecular docking and molecular dynamics
Journal of biomolecular structure and dynamics/Journal of biomolecular structure & dynamics